Solu-cortef and Avandia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-cortef (hydrocortisone sodium succinate) and Avandia (rosiglitazone maleate). Common drug interactions include abscess among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Solu-cortef and Avandia. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

What is Avandia?

Avandia has active ingredients of rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 142,155 Avandia users. Check the latest studies of Avandia.



On Jul, 06, 2026

11 people who take Solu-cortef and Avandia together, and have interactions are studied.

Solu-cortef and Avandia drug interactions.

What are the common drug interactions of Solu-Cortef and Avandia, by gender? *:

female:

  1. Abscess (pus)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Asthma
  4. Blood glucose increased
  5. Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
  6. Cardiac valve disease (heart valve disease)
  7. Cardiomegaly (increased size of heart than normal)
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Cardiovascular disorder (heart diseases)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Nausea (feeling of having an urge to vomit)
  3. Anxiety
  4. Arrhythmia (irregular heartbeat)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Blood triglycerides increased
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Cardiac failure congestive
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Solu-Cortef and Avandia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  2. Blood aldosterone increased
  3. Blood alkaline phosphatase increased
  4. Blood amylase increased
  5. Blood bilirubin increased
  6. Blood corticotrophin increased
  7. Blood glucose increased
  8. Blood sodium decreased
  9. Blood uric acid decreased
  10. Chest pain

50-59:

  1. Chest pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Asthenia (weakness)
  4. Cardiac failure congestive
  5. Abscess (pus)
  6. Asthma
  7. Blood glucose increased
  8. Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiomegaly (increased size of heart than normal)
  10. Cardiomyopathy (weakening of the heart muscle)

60+:

  1. Anaemia (lack of blood)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Nausea (feeling of having an urge to vomit)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Platelet count decreased
  6. Pyrexia (fever)
  7. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  8. White blood cell count decreased
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Cardiac valve disease (heart valve disease)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 3 people, 27.27%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 18.18%
  3. Upper Respiratory Tract Infection: 1 person, 9.09%
  4. Transplant Rejection (a transplant material is not worked): 1 person, 9.09%
  5. Pleural Effusion (water on the lungs): 1 person, 9.09%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
  7. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 9.09%
  8. High Blood Pressure: 1 person, 9.09%
  9. Chest Pain: 1 person, 9.09%
  10. Adrenocortical Insufficiency Acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and Avandia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Solu-cortef and Avandia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avandia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avandia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate and rosiglitazone maleate (the active ingredients of Solu-cortef and Avandia, respectively), and Solu-cortef and Avandia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: